A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects-Reference-Cited by-同舟云学术

A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects

Published:2023-11-09 Issue:2 Volume:42 Page:199-217
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Lamsal Ramesh^ORCID,Yeh E. Ann^ORCID,Pullenayegum Eleanor^ORCID,Ungar Wendy J.^ORCID

Funder

Hospital for Sick Children

Canada Excellence Research Chairs, Government of Canada

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40273-023-01331-1.pdf

Reference159 articles.

1. Canadian Agency for Drugs and Technology in Health (CADTH). Guidelines for the economic evaluation of health technologies: Canada. 4th ed. Ottawa: CADTH; 2017.

2. National Institute of Health and Sciences (NICE). Guide to the methods of technology appraisal. 2004 [cited 2021 February 24 ]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/191504/NICE_guide_to_the_methods_of_technology_appraisal.pdf.

3. National Institute of Health and Sciences (NICE). Guide to the methods of technology appraisal 2013. 2013 [cited 2019 December 1] . https://www.nice.org.uk/process/pmg9/chapter/foreword.

4. Nederland Zorginstituut. Guideline for economic evaluations in healthcare. Diemen: ZIN 2016 [cited 2022 February 24]. https://english.zorginstituutnederland.nl/publications/reports/2016/06/16/guideline-for-economic-evaluations-in-healthcare.

5. Pennington B, Eaton J, Hatswell AJ, Taylor H. Carers’ health-related quality of life in global health technology assessment: guidance, case studies and recommendations. Pharmacoeconomics. 2022;40(9):837–50. https://doi.org/10.1007/s40273-022-01164-4.